TipRanks
Advertisement
Advertisement
Ionis Pharmaceuticals price target lowered to $70 from $76 at JPMorgan
PremiumThe FlyIonis Pharmaceuticals price target lowered to $70 from $76 at JPMorgan
22d ago
Cathie Wood’s ARK Investment buys 100K shares of Ionis Pharmaceuticals today
Premium
The Fly
Cathie Wood’s ARK Investment buys 100K shares of Ionis Pharmaceuticals today
23d ago
Ionis Pharmaceuticals price target lowered to $80 from $89 at Guggenheim
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $80 from $89 at Guggenheim
29d ago
Ionis Pharmaceuticals price target lowered to $54 from $61 at BMO Capital
PremiumThe FlyIonis Pharmaceuticals price target lowered to $54 from $61 at BMO Capital
1M ago
Ionis Pharmaceuticals price target lowered to $85 from $95 at Canaccord
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $85 from $95 at Canaccord
1M ago
Ionis Pharmaceuticals price target lowered to $56 from $69 at Goldman Sachs
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $56 from $69 at Goldman Sachs
1M ago
Novartis announces Phase 3 pelacarsen study did not meet primary endpoint
PremiumThe FlyNovartis announces Phase 3 pelacarsen study did not meet primary endpoint
1M ago
Ionis Pharmaceuticals: Buy Rating Backed by FDA Approval of Zanvastro and Strengthened Neurology Pipeline Upside
Premium
Ratings
Ionis Pharmaceuticals: Buy Rating Backed by FDA Approval of Zanvastro and Strengthened Neurology Pipeline Upside
1M ago
Ionis Pharmaceuticals price target raised to $61 from $60 at BMO Capital
Premium
The Fly
Ionis Pharmaceuticals price target raised to $61 from $60 at BMO Capital
1M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―